These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 6090917)

  • 1. In silico screening of GMQ-like compounds reveals guanabenz and sephin1 as new allosteric modulators of acid-sensing ion channel 3.
    Callejo G; Pattison LA; Greenhalgh JC; Chakrabarti S; Andreopoulou E; Hockley JRF; Smith ESJ; Rahman T
    Biochem Pharmacol; 2020 Apr; 174():113834. PubMed ID: 32027884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of guanabenz in methadone withdrawal.
    Levadi DI
    Am J Psychiatry; 1985 Sep; 142(9):1128-9. PubMed ID: 4025641
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical experience with naltrexone in suburban opioid addicts.
    Tennant FS; Rawson RA; Cohen AJ; Mann A
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):42-5. PubMed ID: 6469935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of presynaptic alpha-mimetics for withdrawal in heroin addicts].
    Gorceix A; Dugarin J; Pommier F
    Ann Med Interne (Paris); 1985; 136(5):389-92. PubMed ID: 2865924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans.
    Donny EC; Walsh SL; Bigelow GE; Eissenberg T; Stitzer ML
    Psychopharmacology (Berl); 2002 May; 161(2):202-12. PubMed ID: 11981600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guanabenz acetate: a new, long-acting alpha-two adrenergic agonist for opioid withdrawal.
    Tennant FS; Rawson RA
    NIDA Res Monogr; 1984 Mar; 49():338-43. PubMed ID: 6090917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current pharmacotherapies for opioid dependence.
    Kosten TR
    Psychopharmacol Bull; 1990; 26(1):69-74. PubMed ID: 2196628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine.
    Gold MS
    Psychiatr Clin North Am; 1993 Mar; 16(1):61-73. PubMed ID: 8456048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic interventions for the treatment of opioid dependence and withdrawal.
    Guthrie SK
    DICP; 1990; 24(7-8):721-34. PubMed ID: 2197814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha2-receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients.
    Honey BL; Benefield RJ; Miller JL; Johnson PN
    Ann Pharmacother; 2009 Sep; 43(9):1506-11. PubMed ID: 19690220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [α2-Agonists during withdrawal].
    Tonner PH; Paris A
    Pharm Unserer Zeit; 2011 Nov; 40(6):481-2. PubMed ID: 22028132
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.